Prometheus Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Prometheus Biosciences

14/05/2021 03:42

* Prometheus Biosciences Inc  RXDX.OQ  reported a quarterly
adjusted loss of $1.67​​ per share for the quarter ended
in March. The mean expectation of four analysts for the quarter
was for a loss of 37 cents per share.
* Revenue was $760.00 thousand​;  analysts expected $200.00
thousand. 
* Prometheus Biosciences Inc's reported EPS for the quarter was
a loss of $1.67​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Prometheus Biosciences Inc shares had fallen by 2.6% this
quarter.
* The company reported a quarterly loss of $13.95 million.
* Wall Street's median 12-month price target for Prometheus
Biosciences Inc is $32.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 14 at 02:42 a.m. GMT.
​All figures in US dollars